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rs2228570Abstract Evidences are growing toward an inhibitory role of vitamin D3 in uterine leiomyoma
pathogenesis. Uterine leiomyoma commonly affects women of reproductive age and is referred to
as one of the most common indications for hysterectomy, worldwide. The effects of vitamin D
are mediated through the vitamin D receptor. A single nucleotide polymorphism of the VDR gene
results in longer protein with decreased activity. The present study has focused on the distribution
of FokI polymorphism in Iranian patients with uterine leiomyoma. Using the PCR-RFLP method
45 cases and 53 controls were assessed. The results demonstrated a correlation between VDR TT
genotype and uterine leiomyoma by Odds Ratio of 1.886 (CI, .767–4.640). The examination of
heterozygous CT genotype also showed the same result by Odds Ratio of 1.875 (CI, .629–5.590).
This study lends support for an increased risk of uterine leiomyoma associated with the VDR
rs2228570 polymorphism. To the best of our knowledge this is the first report regarding VDR FokI
polymorphism in leiomyoma patients.
 2015 The Author. Production and hosting by Elsevier B.V. on behalf of Ain Shams University. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Evidences are growing toward an inhibitory role of vitamin D3
(1,25(OH)2D3) in uterine leiomyoma [1,2].
Uterine leiomyoma which commonly affects women of
reproductive age originates from uterine smooth muscle cells
[3]. This myometrial non-cancerous tumor develops in an
estrogen/progesterone dependent manner [4]. The main com-
pliant of the patients is excessive uterine bleeding although;symptoms depend on the location of the myoma and its size
[3]. It is noteworthy that leiomyoma is referred to as the most
common indication for hysterectomy, worldwide [5]. Twin’s
and family studies revealed a genetic mechanism underlying
leiomyoma [6]. It has been shown that in families with two
or more leiomyoma patients, first-degree members had 2.2
times more chance to develop the disease [7].
In vitro studies revealed that vitamin D has antiestrogenic/
anti progesteronic effect on fibroid cells [2]. The effect of vita-
min D is mediated via the vitamin D receptor (VDR) which
belongs to the nuclear receptor super family [8]. The VDR gene
is mapped on the long arm of chromosome 12 (12q12–14) with
9 exons [9]. A single nucleotide polymorphism (SNP) of the
VDR gene, rs2228570 (FokI), was linked to various patholog-
ical situations such as breast cancer [10]. FokI is a variable site
116 S. Shahbazilocated on exon 2 and presenting a C/T transition (ACG to
ATG) at the translation initiation site. This transition results
in three amino acids longer protein with a poor response to
vitamin D [11].
Using Western blot analysis, it has been reported that myo-
mas express low levels of VDR compared to the adjacent nor-
mal myometrium, suggesting VDR as a risk factor for myoma
pathogenesis [12]. Since FokI polymorphism results in a longer
protein with reduced activity; the present study has focused on
the distribution of FokI polymorphism in Iranian patients suf-
fering from uterine leiomyoma.
2. Subjects and methods
A total of 45 unrelated uterine leiomyoma patients participated
in the study. They were visited by an expert gynecologist and
subjected to imaging and laboratory tests. Diagnostic criteria
were based on the standard international guidelines. In a
case-control design 53 volunteer healthy women without a fam-
ily history of myoma were considered as controls. A question-
naire was applied to interview and a written informed consent
approved by the ethics committee of the Tarbiat Modares
University was obtained from each participant. Work has been
carried out in accordance with The Code of Ethics of theWorld
Medical Association of Helsinki for experiments in humans.
DNA was extracted from 5 ml peripheral blood of patients
and normal subjects by salting out methods and stored at
20 C. The concentration and quality of the DNA was mea-
sured using NanoDrop ND-1000 spectrophotometer at 260
and 280 nm. Fresh DNA working solutions (10–40 ng/lL)
were prepared immediately before experiments. Specific PCR
primers were designed and verified using SNPs database and
BLAST website as follows:
Forward, 50- CTGGCACTGACTCTGGCTCT
Reverse, 50- GGGCTCACCTGAAGAAGCCT
PCR was performed by an initial denaturation step for
5 min at 94 C then 30 amplification cycles of: denaturation
at 95 C for 30 s, annealing at 59 C for 30 s and extension
at 72 C for 30 s. Final extension was allowed to proceed for
5 min at 72 C.
FokI genotyping was conducted by restriction fragment
length polymorphism (RFLP). PCR products were digested
as recommended by the manufacturer’s instruction (Fermen-
tas, Cinaclon, Iran). T allele was not cleaved and presented a
unique 204 bp band, while the C allele yielded 156 and 48 bp
products detected by electrophoresis on 2% agarose gel.
The collected data were loaded on statistical analysis soft-
ware SPSS V.16. Data were analyzed using conditional logistic
regression along with 95% confidence intervals (CIs) in a 2  2
table. Chi-square test was selected to weigh up the null hypoth-
esis (H0) among the groups. The p-values less than 0.05 were
considered to be statistically significant.
3. Results
Subjects mean age was 39.07 ± 12.82 vs. controls with a mean
age of 36.60 ± 13.21 years. The mean gravidity of patients and
controls were 1.98 ± 1.07 and 2.03 ± 1.32, respectively. Data
revealed that most of the lesions are intramural leiomyomas.In addition abnormal uterine bleeding was the most common
chief complaint of the patients following low back pain.
PCR products of all samples showed a unique band with
expected 204 bp on gel electrophoresis (Fig. 1).
As shown in Fig. 2, the rs2228570 SNP desired fragments
were revealed by RFLP on gel.
The VDR rs2228570 SNP allele frequencies were indicated
in Table 1. The minor allele (T) frequency was 0.33 and 0.43 in
controls and cases, respectively. The T allele represents ATG
to ACG alteration, which encodes the translation-initiation
codon of VDR mRNA. As a result, protein translation initi-
ates from upstream ATG codon. TT genotype was detected
in 22% of cases vs. 17% of controls. Statistical analysis uncov-
ers a correlation between VDR TT genotype and uterine
leiomyoma by Odds Ratio of 1.886 (CI, .767–4.640). The
examination of heterozygous CT genotype also demonstrated
the same result by Odds Ratio of 1.875 (CI, .629–5.590).
Results showed no major deviation from the expected
Hardy–Weinberg equilibrium.
4. Discussion
Vitamin D levels have recently been related to the development
of uterine leiomyomas, with examinations proving that lower
1,25(OH)2D3 correlates to a higher risk and larger myomas
[13].
Radioimmunoassay of plasma vitamin D revealed that
levels > 20 ng/ml were associated to a 32% reduced risk of
myoma. The researchers also found that those who reported
spending more than one hour outside (getting sun exposure)
per day had a 40% decreased risk of the disease [2].
The inhibitory role of vitamin D supplementation in the
treatment of myomas has also been found in animal studies.
It has been reported that in rats, intravenous vitamin D3 inhib-
ited the proliferation of fibroid cells and shrank myoma
tumors [14].
Recently, Halder and colleagues discovered that uterine
leiomyoma express reduced levels of VDR compared to the
adjacent normal myometrium. They also suggested 1,25(OH)
2D3 as an effective, safe, nonsurgical treatment option for
human uterine myomas [12].
Furthermore, in uterine leiomyoma an inverse correlation
between levels of VDR and up-regulated ER-a, PR-A, and
PR-B was observed suggesting that 1,25(OH)2D3 functions
as an antagonist of sex steroid hormone receptors in this tissue
[15].
VDR gene polymorphisms have been shown to be involved
in several cancers including breast and colon. Two comprehen-
sive case-control studies correlate rs2228570 TT genotype to a
higher risk of breast cancer [10,16]. But some others have not
supported this correlation [11,17].
In vitro study provided evidence that rs2228570 CC
genotype enhances VDR gene expression by interaction with
transcription Factor IIB [18].
Besides VDR gene, the polymorphisms of the genes
involved in vitamin D metabolism and skin pigmentation
including rs12800438 and rs6058017 were also significantly
associated with leiomyoma [19].
In the present study, SNP rs2228570 was genotyped in a
case/control design in Iranian leiomyoma patients. Given
the fact that vitamin D functions are mediated via VDR,
Figure 1 Expected 204 bp PCR unique bands on gel electrophoresis. Lane 1 represents the 100 bp DNA ladder.
Figure 2 RFLP results of VDR FokI polymorphism. Lanes 1
and 7 represent the 100 bp DNA ladder and undigested PCR
product, respectively. Lane 5 shows the CC genotype and Lanes 3,
6 show the TT genotype. Heterozygous CT genotype is shown in
lanes 2, 4.
Table 1 The allele frequencies determined for VDR rs2228570
SNP among the study cases and controls.
Subjects Genotypes Genotype
frequency (%)
Allele
frequency
Cases CC 16 (35.5) C allele = 0.57
CT 19 (42.5)
TT 10 (22) T allele = 0.43
Total 45
Controls CC 27 (51) C allele = 0.67
CT 17 (32)
TT 9 (17) T allele = 0.33
Total 53
Link between VDR rs2228570 and uterine leiomyoma 117FokI polymorphism could impact on the development of
leiomyoma.
This study lends support to the view that uterine leiomy-
oma is associated with the VDR rs2228570 polymorphism,
although, it requires the performance of multicenter studies
on a larger number samples to get more valid and reliablevalues. To the best of our knowledge this is the first report
regarding VDR FokI polymorphism in leiomyoma patients.
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